David Moskowitz
David focuses on the Bio-IT space.
Prior to joining 8VC, David completed his Ph.D. in Biomedical Informatics at Stanford University, where he concurrently received an M.S. in Statistics. His research focused on the development of statistical and machine learning approaches for analyzing genomics data, and the characterization of epigenetic changes associated with aging in T cells.
Previously, David was a Bioinformatic Analyst at Einstein College of Medicine, where he worked on the genetics of aging and human disease. He performed his undergraduate studies in Computational Biology at Brown University.
What’s a Rich Text element?
The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.
Static and dynamic content editing
A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!
How to customize formatting for each rich text
Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.
8VC’s Investment in Ushur, Intelligent Automation for Client-Facing Workflows
Since leading Ushur’s Series A in 2018, we have watched them dramatically grow their intelligent automation (IA) capabilities and traction. We are excited to announce 8VC’s participation in Ushur’s $25M Series B, led by Third Point Ventures, alongside Pentland Group. We are thrilled to be continuing to partner with Ushur as they revamp insurance, financial services, and healthcare.
8VC’s Investment in Ushur, Intelligent Automation for Client-Facing Workflows
Since leading Ushur’s Series A in 2018, we have watched them dramatically grow their intelligent automation (IA) capabilities and traction. We are excited to announce 8VC’s participation in Ushur’s $25M Series B, led by Third Point Ventures, alongside Pentland Group. We are thrilled to be continuing to partner with Ushur as they revamp insurance, financial services, and healthcare.
8VC’s Investment in Mantra Bio
Paul Ehrlich, one of the forefathers of modern medicine, famously proposed the idea of a “magic bullet” that would selectively kill pathogens while sparing the body. His research led to the first drug for syphilis and established the chemistry-driven paradigm of therapeutics that would persist for the next 70 years. Unfortunately, it turned out that there is no simple way to achieve arbitrary targeting of cytotoxic chemical compounds, and these magic bullet treatments proved difficult to reproduce. The lack of precision delivery presents pharma with a double-edged sword: higher doses with elevated toxicity, or lower doses that are potentially inefficacious.
8VC’s Investment in Mantra Bio
Paul Ehrlich, one of the forefathers of modern medicine, famously proposed the idea of a “magic bullet” that would selectively kill pathogens while sparing the body. His research led to the first drug for syphilis and established the chemistry-driven paradigm of therapeutics that would persist for the next 70 years. Unfortunately, it turned out that there is no simple way to achieve arbitrary targeting of cytotoxic chemical compounds, and these magic bullet treatments proved difficult to reproduce. The lack of precision delivery presents pharma with a double-edged sword: higher doses with elevated toxicity, or lower doses that are potentially inefficacious.
Announcing Our Investment in Orca Bio
Every year in America, roughly 23,000 people undergo a Bone Marrow Transplant (BMT). These procedures are typically last-line interventions to save cancer patients. When successful, the therapy is often curative.
Announcing Our Investment in Orca Bio
Every year in America, roughly 23,000 people undergo a Bone Marrow Transplant (BMT). These procedures are typically last-line interventions to save cancer patients. When successful, the therapy is often curative.
8VC’s Investment in Unlearn.AI
Imagine you have an incurable disease — maybe Alzheimer’s or multiple sclerosis. Though you might be willing to take a chance on science, you would nonetheless face a difficult decision in choosing whether to volunteer for a clinical trial.
8VC’s Investment in Unlearn.AI
Imagine you have an incurable disease — maybe Alzheimer’s or multiple sclerosis. Though you might be willing to take a chance on science, you would nonetheless face a difficult decision in choosing whether to volunteer for a clinical trial.
Meet more of our team
Meet more of our advisors
